Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul 17:8:2050313X20939481.
doi: 10.1177/2050313X20939481. eCollection 2020.

Super giant basal cell carcinoma in an autistic patient: A case report

Affiliations
Case Reports

Super giant basal cell carcinoma in an autistic patient: A case report

Emma Hudson et al. SAGE Open Med Case Rep. .

Abstract

Basal cell carcinoma is the most common skin cancer in the world and is generally treated when small in size with an excellent prognosis. Rarely, basal cell carcinoma will grow to be larger than 5 cm, at which point they are termed giant basal cell carcinoma. Giant basal cell carcinoma comprises only 0.5% of all basal cell carcinoma, but is associated with impaired quality of life and increased risk of metastasis. When a basal cell carcinoma grows to over 20 cm in size, it is termed super giant basal cell carcinoma. Here, we report a case of both a super-giant basal cell carcinoma and a giant basal cell carcinoma developing over 10-12 years on the upper back and anterior chest wall of an autistic male. Generally, this presentation is associated with neglect on the part of the patient. This case report demonstrates a super-giant basal cell carcinoma developing secondary to patient neglect in the context of comorbid mental illness.

Keywords: Super-giant basal cell carcinoma; Vismodegib; autism; cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Sharply demarcated, friable ulcer on the upper mid-back.
Figure 2.
Figure 2.
Eroding, necrotic tumor on the left anterior chest wall.
Figure 3.
Figure 3.
Skin punch biopsy (HE 2×) from the left chest demonstrating variably sized lobules and infiltrating strands composed of basaloid cells with peripheral palisading and focal stromal retraction (HE 10×). Basaloid cells demonstrating variable atypia with large nuclei, prominent nucleoli, and multiple apoptotic bodies and mitotic figures including atypical forms (HE 20×).

References

    1. Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res 2009; 29(7): 2655–2663. - PubMed
    1. Desmond B, Boudreaux L, Young J. A rare case of super giant basal cell carcinoma. JAAD Case Rep 2015; 1(5): 280–282. - PMC - PubMed
    1. Lorenzo SD, Zabbia G, Corradino B, et al. A rare case of giant basal cell carcinoma of the abdominal wall: excision and immediate reconstruction with a pedicled deep inferior epigastric artery perforator (DIEP) flap. Am J Case Rep 2017; 18: 1284–1288. - PMC - PubMed
    1. Randle HW, Roenigk RK, Brodland DG. Giant basal cell carcinoma (T3): who is at risk? Cancer 1993; 72(5): 1624–1630. - PubMed
    1. Raymaker DM, Mcdonald KE, Ashkenazy E, et al. Barriers to healthcare: instrument development and comparison between autistic adults and adults with and without other disabilities. Autism 2016; 21(8): 972–984. - PMC - PubMed

Publication types

LinkOut - more resources